Aspen Pharmacare Price to Free Cash Flow Ratio 2017-2023 | APNHY
Historical price to free cash flow ratio values for Aspen Pharmacare (APNHY) since 2017.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Aspen Pharmacare Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 0.00 | nan | ||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $5.038B | $2.296B |
| Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $14.855B | 5.36 |
| Dr Reddy's Laboratories (RDY) | India | $12.352B | 19.53 |
| BridgeBio Pharma (BBIO) | United States | $4.278B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $3.150B | 2.46 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.995B | 13.66 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.604B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.430B | 0.00 |
| Generation Bio (GBIO) | United States | $0.200B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.073B | 0.00 |
| Personalis (PSNL) | United States | $0.063B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.028B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.024B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |